Condition
Endometrioid Endometrial Adenocarcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Endometrioid Endometrial Adenocarcinoma clinical trials that are recruiting, at sites in 2 countries (most in Australia (1), United States (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Adding a GLP‑1 weight‑loss medicine to a levonorgestrel IUD for obese patients with endometrial precancer or low‑grade cancer
This Phase 2 trial will test whether giving a GLP‑1 weight‑loss medicine together with a levonorgestrel IUD helps obese adults with endometrial intraepithelial neoplasia or grade 1 endometrioid cancer who cannot or do not want a hysterectomy.
-
Evaluating dostarlimab as a non-surgical treatment for early-stage endometrial cancer
This study is testing if a new immunotherapy drug called dostarlimab can be a safe and effective non-surgical treatment for women with early-stage endometrial cancer who want to keep their fertility or can't have surgery.
Related topics
Quick answers
How many Endometrioid Endometrial Adenocarcinoma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Australia (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.